Health Care Roundup: Market Talk
0833 GMT – Chinese shares closed mixed amid cautious sentiment as investors wait for signs that Beijing will take stronger measures to support the economy. The benchmark Shanghai Composite Index end...
- Supported exchanges /
- SHE /
- 300759.SHE
Pharmaron Beijing Co Ltd (300759 SHE) stock market data APIs
¥28.28
1.56(5.8%)
as of November 22, 2024
Price chart is built with Anychart
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Pharmaron Beijing Co Ltd Financial Data Overview
| 26.72 | |
| 28.28 | |
| - | |
| 28.32 | |
| 26.66 | |
| 17.6947-36.42 | |
| 49 100 M | |
| 28.5 | |
| 1 486 M | |
| 11 795 M | |
| 0.1725 | |
| 0.0064 | |
| 0.835 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'300759',
Type:
'Common Stock',
Name:
'Pharmaron Beijing Co Ltd',
Exchange:
'SHE',
CurrencyCode:
'CNY',
CurrencyName:
'Renminbi',
CurrencySymbol:
'¥',
CountryName:
'China',
CountryISO:
'CN',
OpenFigi:
NULL,
ISIN:
'CNE100003JW4',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Pharmaron Beijing Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 11 795 M
- EBITDA 2 388 M
- Earnings Per Share 1.06
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Pharmaron Beijing Co Ltd Earnings via APIs
- Latest Release 2024-10-29
- EPS/Forecast 0.24
Get Pharmaron Beijing Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Pharmaron Beijing Co Ltd latest news via APIs
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
Building capacity in Gene Therapy BEIJING, March 29, 2023--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that their Liverpool, UK based...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
